The glomerular sclerosis, mesangiolysis, and the tubulointerstitial sclerosis index were not changed by the treatment, with the exception that mesangiolysis increased in the angiotensin II-treated Nox4 knockout animals. This evidence concerns the gene AGT and glomerulosclerosis.